Vaccine Breakthrough Severe COVID-19 in a Lung Recipient

The vaccines developed against severe acute respiratory syndrome coronavirus 2 are seen as the most crucial weapon in controlling the epidemic. It has been reported in early-stage vaccine studies that vaccines provide up to 95% protection against severe disease and mortality, even in the absence of...

Descripción completa

Detalles Bibliográficos
Autores principales: Beyoglu, Muhammet Ali, Sahin, Mehmet Furkan, Turkkan, Sinan, Basaran, Fatmanur Celik, Yazicioglu, Alkin, Bektas, Serife Gokbulut, Tekce, Yasemin Tezer, Yekeler, Erdal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8585586/
https://www.ncbi.nlm.nih.gov/pubmed/34887098
http://dx.doi.org/10.1016/j.transproceed.2021.11.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8585586/
https://www.ncbi.nlm.nih.gov/pubmed/34887098
http://dx.doi.org/10.1016/j.transproceed.2021.11.003

Ejemplares similares